The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Procept BioRobotics Corp’s stock clocked out at $95.46, down -1.66% from its previous closing price of $97.07. In other words, the price has decreased by -$1.66 from its previous closing price. On the day, 0.84 million shares were traded. PRCT stock price reached its highest trading level at $98.88 during the session, while it also had its lowest trading level at $94.64.
Ratios:
To gain a deeper understanding of PRCT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.07 and its Current Ratio is at 6.02. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 11, 2023, initiated with a Overweight rating and assigned the stock a target price of $42.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 05 ’24 when 222 DNA TRUST bought 100,000 shares for $97.07 per share.
Zadno Reza sold 288,461 shares of PRCT for $26,249,951 on Oct 30 ’24. The President, CEO now owns 258,445 shares after completing the transaction at $91.00 per share. On Oct 15 ’24, another insider, Waters Kevin, who serves as the EVP, CFO of the company, sold 25,000 shares for $72.47 each. As a result, the insider received 1,811,653 and left with 96,096 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 5164987392 and an Enterprise Value of 4867282944. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.98 while its Price-to-Book (P/B) ratio in mrq is 20.64. Its current Enterprise Value per Revenue stands at 24.356 whereas that against EBITDA is -48.019.
Stock Price History:
Over the past 52 weeks, PRCT has reached a high of $99.34, while it has fallen to a 52-week low of $29.71. The 50-Day Moving Average of the stock is 21.82%, while the 200-Day Moving Average is calculated to be 51.74%.
Shares Statistics:
It appears that PRCT traded 848.25K shares on average per day over the past three months and 1666280 shares per day over the past ten days. A total of 50.77M shares are outstanding, with a floating share count of 48.95M. Insiders hold about 5.74% of the company’s shares, while institutions hold 85.26% stake in the company. Shares short for PRCT as of 1728950400 were 6706552 with a Short Ratio of 7.91, compared to 1726185600 on 5695289. Therefore, it implies a Short% of Shares Outstanding of 6706552 and a Short% of Float of 17.629998999999998.
